Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Locus Biosciences
Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria
January 07, 2026
From
Locus Biosciences
Via
Business Wire
Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases
August 12, 2024
From
Locus Biosciences
Via
GlobeNewswire
Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy
January 23, 2024
From
Locus Biosciences
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.